Tirzepatide Shows 50% More Weight Loss Than Semaglutide in First Head-to-Head Study Dr. Kamal Kant Kohli13 May 2025 9:15 AM ISTIn the first direct comparison study involving individuals with obesity, tirzepatide demonstrated approximately 50% greater weight loss compared to...
Switching to Tirzepatide better than Increasing Dulaglutide Dose in poorly controlled Type 2 Diabetes: Study Dr Riya Dave9 April 2025 9:00 AM ISTResearchers have found in a new research that among patients with poorly controlled type 2 diabetes, switching from dulaglutide to tirzepatide...
Medical Bulletin 03/ April/ 2025 Dr. Bhumika Maikhuri3 April 2025 3:00 PM ISTHere are the top health news for the day:Human Heat Tolerance Lower Than Previously Believed: Study FindsA study from the University of Ottawa’s Human...
Trial Shows Tirzepatide May Benefit People with Obesity, Kidney Disease and Heart Failure Dr. Bhumika Maikhuri3 April 2025 8:15 AM ISTThe drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection...
Tirzepatide Leads to Significant Weight Loss and Better Heart & Kidney Health in Type 1 Diabetes: Study Finds Medha Baranwal29 March 2025 9:00 AM ISTUSA: A recent study has highlighted the potential benefits of tirzepatide for overweight and obese adults with type 1 diabetes (T1D). Over 21 months,...
Anti-Obesity Drugs Tirzepatide and Semaglutide Offer Health Benefits but Cost found prohibitive: New Research Shows Medha Baranwal20 March 2025 9:30 AM ISTUSA: A recent economic evaluation has highlighted the significant long-term health benefits of tirzepatide and semaglutide in managing obesity among...
Tirzepatide Lowers albuminuria among Type 2 Diabetes Patients: Study Dr Riya Dave17 Feb 2025 9:00 PM ISTA post hoc analysis of trial data published in Diabetes Care found that adults with type 2 diabetes receiving tirzepatide experienced greater...
Neuro-ophthalmologists concerned over Ophthalmic complications in patients on antidiabetic GLP-1 medications: JAMA Dr. Kamal Kant Kohli14 Feb 2025 8:15 PM IST A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link...
Use of Semaglutide and tirzepatide use linked to ophthalmic complications, finds study Jacinthlyn Sylvia5 Feb 2025 9:00 PM ISTAlmost 2% of the U.S. population received prescriptions for the weight-loss and diabetes drugs semaglutide and tirzepatide in 2023. These medications,...
GLP-1 drugs may reduce surgery complications in patients with diabetes, suggests study Dr. Kamal Kant Kohli15 Jan 2025 8:45 AM ISTPeople with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of hospital...
Copycat weight-loss drugs: Eli Lilly sues two medical spas Ruchika Sharma14 Jan 2025 5:28 PM ISTTwo medical spas have been sued by Eli Lilly for selling unapproved products that claim to contain tirzepatide. Tirzepatide is the main ingredient in...
GLP-1 Drugs May Lower Surgical Complications in Diabetes Patients: Study Finds Dr. Bhumika Maikhuri9 Jan 2025 8:15 AM ISTPeople with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of hospital...
